Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.2913
-0.0138 (-4.52%)
At close: Apr 1, 2025, 4:00 PM
0.2815
-0.0098 (-3.36%)
Pre-market: Apr 2, 2025, 4:42 AM EDT

Leap Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-67.79-81.41-54.6-40.59-27.51
Upgrade
Depreciation & Amortization
0.010.020.020.030.03
Upgrade
Other Amortization
---0.140.14
Upgrade
Asset Writedown & Restructuring Costs
-29.58---
Upgrade
Stock-Based Compensation
5.55.135.183.692.57
Upgrade
Other Operating Activities
0.690.431.010.57-0.19
Upgrade
Change in Accounts Payable
0.90.710.953.9-2.6
Upgrade
Change in Unearned Revenue
----1.51.5
Upgrade
Change in Income Taxes
0.56----
Upgrade
Change in Other Net Operating Assets
-0.171.8-1.75-1.40.15
Upgrade
Operating Cash Flow
-60.3-43.75-49.04-35.16-25.96
Upgrade
Capital Expenditures
--1.39---
Upgrade
Sale of Property, Plant & Equipment
----0.03
Upgrade
Cash Acquisitions
-50.36---
Upgrade
Investing Cash Flow
-48.97--0.03
Upgrade
Issuance of Common Stock
40.13--98.2248.92
Upgrade
Repurchase of Common Stock
--0---
Upgrade
Other Financing Activities
-2.95-0.03-0.21-0.18-1.91
Upgrade
Financing Cash Flow
37.18-0.03-0.2198.0474
Upgrade
Foreign Exchange Rate Adjustments
-0.28-0.04-0.16-0.030.12
Upgrade
Net Cash Flow
-23.395.14-49.4262.8548.18
Upgrade
Free Cash Flow
-60.3-45.15-49.04-35.16-25.96
Upgrade
Free Cash Flow Margin
----2343.80%-1730.47%
Upgrade
Free Cash Flow Per Share
-1.61-2.21-4.33-4.10-4.38
Upgrade
Cash Income Tax Paid
--2.3-1.1-0.1-0.3
Upgrade
Levered Free Cash Flow
-36.72-46.85-28.27-20.46-15.67
Upgrade
Unlevered Free Cash Flow
-36.72-46.85-28.24-20.44-15.65
Upgrade
Change in Net Working Capital
-1.55-3.11-0.76-0.840.9
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q